The endothelium responds to numerous chemical and mechanical factors in regulating vascular tone, blood pressure, and blood flow. The endothelial volume-regulated anion channel (VRAC) has been proposed to be mechanosensitive and thereby sense fluid flow and hydrostatic pressure to regulate vascular function. Here, we show that the leucine-rich repeat-containing protein 8a, LRRC8A (SWELL1), is required for VRAC in human umbilical vein endothelial cells (HUVECs). Endothelial LRRC8A regulates AKT-endothelial nitric oxide synthase (eNOS) signaling under basal, stretch, and shear-flow stimulation, forms a GRB2-Cav1-eNOS signaling complex, and is required for endothelial cell alignment to laminar shear flow. Endothelium-restricte

Abello, Javier

Alghanem, Ahmad F

et al,

Gunasekar, Susheel K

Kang, Chen

Kumar, Ashutosh

Maurer, Joshua M

Sah, Rajan

Stratman, Amber N

Ta, Chau My

Xie, Litao

English

Digital Commons@Becker

Figures and figure supplementsThe SWELL1-LRRC8 complex regulates endothelial AKT-eNOS signaling andvascular functionAhmad F Alghanem et alAlghanem et al. eLife 2021;10:e61313. DOI: https://doi.org/10.7554/eLife.61313 1 of 23RESEARCH ARTICLEFigure 1. Leucine-rich repeat-containing protein 8a (LRRC8A) mediates volume-regulated anion channel (VRAC) currents in human umbilical veinendothelial cells (HUVECs). (A) LRRC8A Western blot in HUVECs transduced with adenovirus expressing a short-hairpin RNA directed to LRRC8A (Ad-shLrrc8a) compared to control scrambled short-hairpin RNA (Ad-shScr). GAPDH is used as loading control. (B) Immunofluorescence staining of theHUVECs transduced with Ad-shLrrc8a and Ad-shScr. (C) Current-time relationship of VRAC current (hypotonic, 210 mOsm) in Ad-shScr transducedHUVEC and co-application of 10 mM 4-(2-butyl-6,7-dichloro-2-cyclopentyl-indan-1-on-5-yl) oxobutyric acid (DCPIB). (D) Representative current tracesupon hypotonic activation (left) during voltage steps (from -100 to +100 mV, shown in inset) and inhibition by DCPIB (right). (E) Current-voltageFigure 1 continued on next pageAlghanem et al. eLife 2021;10:e61313. DOI: https://doi.org/10.7554/eLife.61313 2 of 23Research article Cell BiologyFigure 1 continuedrelationship of VRAC during voltage ramps from -100 mV to +100 mV after hypotonic swelling in HUVECs transduced with Ad-shScr and Ad-shLrrc8a.(F) Mean current outward and inward densities at +100 and -100 mV (n,shSCR=4 cells; n,shLrrc8a=6 cells). Data are shown as mean ± s.e.m. *p<0.05;**p<0.01; unpaired t-test for (F).Alghanem et al. eLife 2021;10:e61313. DOI: https://doi.org/10.7554/eLife.61313 3 of 23Research article Cell BiologyFigure 2. Leucine-rich repeat-containing protein 8a (LRRC8A) regulates PI3K-AKT-endothelial nitric oxide synthase (eNOS), ERK signaling inendothelium. (A) Western blots of LRRC8A, pAkt2, pAkt1, Akt2, Akt1, pErk1/2, Erk1/2, phosphorylated eNOS (p-eNOS), eNOS, pS6K ribosomal protein,S6K ribosomal protein, GAPDH, and ß-actin in Ad-shScr and Ad-shLrrc8a transduced human umbilical vein endothelial cells (HUVECs) under basalconditions. Quantification of LRRC8A/ß-actin (B), p-eNOS/ß-actin, p-eNOS/total eNOS (C), pAkt2/ß-actin, pAkt2/total Akt2 (D), pAkt1/GAPDH, pAkt1/total Akt1 (E), pERK1/2/GAPDH, pErk1/2/total Erk1/2 (F), pS6 ribosomal protein/GAPDH, and pS6K ribosomal protein/total S6K ribosomal protein (G).N = 6 independent experiments. Significance between the indicated groups in all blots was calculated using a two-tailed unpaired Student’s t-test.Data are shown as mean ± s.e.m. *p<0.05; **p<0.01; ***p<0.001.Alghanem et al. eLife 2021;10:e61313. DOI: https://doi.org/10.7554/eLife.61313 4 of 23Research article Cell BiologyFigure 2—figure supplement 1. Leucine-rich repeat-containing protein 8a (LRRC8A) regulates PI3K-AKT-endothelial nitric oxide synthase (eNOS) andERK signaling in endothelium. (A) Western blots of LRRC8A, pAkt2, pAkt1, Akt, pErk1/2, Erk1/2, phosphorylated eNOS (p-eNOS), eNOS, pS6Kribosomal protein, S6K ribosomal protein, and ß-actin in si-SCR and si-LRRC8A transfected human umbilical vein endothelial cells (HUVECs) under basalconditions. Quantification of LRRC8A/ß-actin (B), p-eNOS/ß-actin, p-eNOS/total eNOS (C), pAkt2/ß-actin, pAkt2/total Akt (D), pAkt1/ß-actin, pAkt1/total Akt (E), pERK1/2 /ß-actin, pErk1/2/total Erk1/2 (F), pS6 ribosomal protein/ß-actin, and pS6K ribosomal protein/total S6K ribosomal protein (G).Figure 2—figure supplement 1 continued on next pageAlghanem et al. eLife 2021;10:e61313. DOI: https://doi.org/10.7554/eLife.61313 5 of 23Research article Cell BiologyFigure 2—figure supplement 1 continuedN = 6 independent experiments. Significance between the indicated groups in all blots was calculated using a two-tailed Student’s t-test. Error barsrepresent mean ± s.e.m. *p<0.05; **p<0.01; ***p<0.001.Alghanem et al. eLife 2021;10:e61313. DOI: https://doi.org/10.7554/eLife.61313 6 of 23Research article Cell BiologyFigure 3. Leucine-rich repeat-containing protein 8A (LRRC8A) interacts with Grb2, Cav1, and endothelial nitric oxide synthase (eNOS) in humanendothelium. (A) GRB2 immunoprecipitation from Ad-shScr and Ad-shLrrc8a transduced human umbilical vein endothelial cells (HUVECs) andFigure 3 continued on next pageAlghanem et al. eLife 2021;10:e61313. DOI: https://doi.org/10.7554/eLife.61313 7 of 23Research article Cell BiologyFigure 3 continuedimmunoblot with LRRC8A, Cav1, and GRB2 antibodies. Densitometry values for GRB2 co-immunoprecipitated LRRC8A (LRRC8A/GRB2) and GRB2 co-immunoprecipitated Cav1 (Cav1/GRB2). GAPDH serves as loading control for input samples. (B) GRB2 immunoprecipitation from Ad-shScr and Ad-shLrrc8a transduced HUVECs and immunoblot with LRRC8A, eNOS, Cav1, and GRB2 antibodies. Insulin stimulation: 100 nM insulin for 10 min.Densitometry values for GRB2 co-immunoprecipitated eNOS (eNOS/GRB2). Representative blots from three independent experiments. (C)Representative endogenous LRRC8A and eNOS immunofluorescence staining in Ad-shScr and Ad-shLrrc8a transduced HUVECs. Representative imagefrom six independent experiments. (D–E) Quantification of LRRC8A (D, n = 6) and eNOS (E, n = 6) immunofluorescence staining upon LRRC8A knock-down (KD). Evidence of LRRC8A-eNOS co-localization (C, insets) in plasma membrane (i) and perinuclear regions (ii). Significance between the indicatedgroups is calculated using an unpaired two-tailed Student’s t-test. p-Values are indicated on figures. Data are shown as mean ± s.e.m.***p<0.001.Alghanem et al. eLife 2021;10:e61313. DOI: https://doi.org/10.7554/eLife.61313 8 of 23Research article Cell BiologyFigure 3—figure supplement 1. Leucine-rich repeat-containing protein 8a (LRRC8A) co-localizes with endothelial nitric oxide synthase (eNOS) andregulates eNOS expression. LRRC8A (green) and eNOS (red) immunofluorescence staining of human umbilical vein endothelial cell (HUVEC)transduced with either Ad-shScr (left) or Ad-shLrrc8a (right). Scale bar is 20 mm. DAPI (blue) labels nuclei.Alghanem et al. eLife 2021;10:e61313. DOI: https://doi.org/10.7554/eLife.61313 9 of 23Research article Cell BiologyFigure 4. Leucine-rich repeat-containing protein 8a (LRRC8A) is required for intact stretch-induced AKT-endothelial nitric oxide synthase (eNOS)signaling. (A) Western blot of LRRC8A, pAKT1, pAKT2, pERK1/2 in response to 30 min of 0.1% and 5% static stretch in Ad-shScr (n = 3) and Ad-shLrrc8a(n = 3) transduced human umbilical vein endothelial cells (HUVECs). GAPDH is used as a loading control. (B–D) Densitometry quantification from A ofpAKT1 (B), pAKT2 (C), and pErk1/2 (D). (E) Western blot of peNOS, LRRC8A, in response to 5% static stretching for 5, 60, and 180 min in Ad-shScr(n = 3) and Ad-shLrrc8a (n = 3) transduced HUVECs. (F) Densitometry quantification from E of eNOS. GAPDH is used as a loading control. Statisticalsignificance between the indicated group is calculated using one-way analysis of variance (ANOVA), Tukey’s multiple comparisons test for (B–D), andtwo-way ANOVA for (F) with p-value in upper left corner. Data are shown as mean ± s.e.m. *p<0.05; **p<0.01; ***p<0.001.Alghanem et al. eLife 2021;10:e61313. DOI: https://doi.org/10.7554/eLife.61313 10 of 23Research article Cell BiologyFigure 5. Leucine-rich repeat-containing protein 8a (LRRC8A) depletion impairs human umbilical vein endothelial cell (HUVEC) alignment to thedirection of shear flow. (A) Cartoon of depicting the laminar shear flow applied to HUVEC at 15 dyne/cm2 for 0, 2, and 24 hr. (B) Bright field image ofFigure 5 continued on next pageAlghanem et al. eLife 2021;10:e61313. DOI: https://doi.org/10.7554/eLife.61313 11 of 23Research article Cell BiologyFigure 5 continuedHUVECs transfected with siScr (top) and siLrrc8a (bottom) with no flow (left) and after 24 hr of flow (right). (C) Distributions of angle of HUVECorientation relative to the direction of flow at 0 hr and after 24 hr of laminar shear flow in siScr-treated cells (top, 0 hr: n = 800; 24 hr: n = 800) andsiLrrc8a treated cells (bottom, 0 hr: n = 600; 24 hr: 800). Cuboidal or symmetrical cells at 0 hr were measured as 90o to the direction of flow. (D)Distributions of angle of HUVEC orientation relative to the direction of flow at 24 hr siScr (black, n = 803) and siLrrc8a treated cells (red, n = 803). (E)Mean alignment to direction of flow of siScr (black, n = 803) and siLrrc8a treated cells (red, n = 803). (F) Mean time required for HUVEC to align towithin 20o of the direction of shear flow in siScr (black, n = 110) and siLrrc8a treated cells (red, n = 110). (G) Mean HUVEC length-width ratio over timeupon stimulation with shear flow in siScr (black, n = 157) and siLrrc8a treated cells (red, n = 157). (H) Representative HUVEC real-time cell trackingduring the 24 hr period of shear flow. Arrow heads represent the direction of travel against the direction of shear flow. (I) Average velocity calculatedfrom the mean distance traveled over the 24 hr period of shear flow (nsiScr = 77; nsiLrrc8a = 78). (J) Representative phosphorylated endothelial nitric oxidesynthase (p-eNOS) immunofluoresence (green) under conditions of no flow (n = 100), 2 hr (n = 100, top) and no flow (n = 110), 24 hr flow (n = 110,bottom). (K–L) Quantification of non-nuclear p-eNOS immunofluoresence (K) and whole-cell p-eNOS (L) under conditions of no flow (n = 100) and 2 hrflow (n = 100). (M–N) Quantification of non-nuclear p-eNOS immunofluoresence (M) and whole-cell p-eNOS (N) under conditions of no flow (n = 110)and 24 hr flow (n = 110). Statistical significance between the indicated values is calculated using a two-tailed Student’s t-test for (E), (F), and (I), usingone-way analysis of variance (ANOVA), Tukey’s multiple comparisons test for (K), (L), (M), and (N), and using two-way ANOVA with Bonferroni multiplecomparison test in (G). In (G), p<0.001 for the time dependence of siScr versus siLrrc8a treated cells, and p<0.001 for the 24 hr timepoint. Error barsrepresent mean ± s.e.m. n = 3, independent experiments. **p<0.01 and ***p<0.001.Alghanem et al. eLife 2021;10:e61313. DOI: https://doi.org/10.7554/eLife.61313 12 of 23Research article Cell BiologyFigure 5—figure supplement 1. Leucine-rich repeat-containing protein 8a (LRRC8A) knock-down abrogates shear-flow stimulatedphosphorylated endothelial nitric oxide synthase (p-eNOS) in human umbilical vein endothelial cells (HUVECs). (A) Representative p-eNOSimmunofluorescence image of siScr and siLrrc8a transfected HUVEC after 24 hr of shear-flow stimulation, using anti-p-eNOS antibody (Cat#9571, fromCell Signaling). (B-C) Quantification of p-eNOS immunofluorescence intensity from non-nuclear regions (B) and from the entire cell (C). Significancebetween the indicated groups was calculated using a two-tailed Student’s t-test. Error bars represent mean ± s.e.m. *p<0.05; **p<0.01;***p<0.001.Alghanem et al. eLife 2021;10:e61313. DOI: https://doi.org/10.7554/eLife.61313 13 of 23Research article Cell BiologyFigure 6. RNA sequencing of Ad-shScr and Ad-shLrrc8a transduced human umbilical vein endothelial cells (HUVECs). (A) Heatmap analysis displayingtop 25 upregulated or 25 downregulated genes between shScr and shLrrc8a. (B) IPA canonical pathway analysis of genes significantly regulated byFigure 6 continued on next pageAlghanem et al. eLife 2021;10:e61313. DOI: https://doi.org/10.7554/eLife.61313 14 of 23Research article Cell BiologyFigure 6 continuedshLrrc8a in comparison to shScr n = 3 for each group. For analysis with Ingenuity Pathway Analysis (IPA), Fragments Per Kilobase of transcripts perMillion mapped reads (FPKM) cutoffs of 1.5, fold change of 1.5, and false discovery rate <0.05 were utilized for significantly differentially regulatedgenes. (C) Expression levels of select LRRC8 mRNA, classic endothelial markers, and mechanoresponsive ion channels in shScr and shLrrc8a-treatedHUVECs. (D) Expression levels LRRC8a-e mRNA in HUVECs compared to data previously published from C2C12 myotubes (Kumar et al., 2020) anddifferentiated 3T3-F442A adipocytes (Zhang et al., 2017). For (C), statistical significance between the indicated values was calculated using an unpairedtwo-tailed Student’s t-test. Error bars represent mean ± s.e.m. n = 3, independent experiments. *p<0.05; **p<0.01; ***p<0.001.Alghanem et al. eLife 2021;10:e61313. DOI: https://doi.org/10.7554/eLife.61313 15 of 23Research article Cell BiologyFigure 7. Endothelial-targeted Lrrc8a KO mice exhibit reduced phosphorylated endothelial nitric oxide synthase (p-eNOS) and mild angiotensin-IIstimulated hypertension. (A) Strategy for endothelium targeted Lrrc8a ablation to generate eLrrc8a KO. (B) Isolation of murine primary endothelial cellsFigure 7 continued on next pageAlghanem et al. eLife 2021;10:e61313. DOI: https://doi.org/10.7554/eLife.61313 16 of 23Research article Cell BiologyFigure 7 continuedfrom WT and eLrrc8a KO using tdTomato reporter mice. (C–D) Current-voltage relationships of volume-regulatory anion channel (VRAC) current inisotonic (Iso, 300 mOsM) and hypotonic (Hypo, 210 mOsm) solution in response to voltage ramps from -100 to +100 mV over 500 ms in WT (C) and KO(D) primary murine endothelial cells. DCPIB (10 mM) inhibition in C (WT). (E) Mean outward (+100 mV) and inward (-100 mV) currents from WT (n = 3cells) and eLrrc8a KO (n = 3 cells). (F) Ex vivo aorta sprouting assay performed in aortic rings isolated from WT and eLrrc8a KO mice and cultured inFGM media for 3 days at 37˚C. Immunofluorescence staining with antibodies to LRRC8A (green), CD31 (red), LRRC8A+CD31+ (Merge) demonstratingendothelial-targeted Lrrc8a deletion. (G) Quantification of LRRC8A immunofluorescence staining in WT (n = 15) and eLrrc8a KO (n = 15) endothelial celltubes. (H–I) Representative images of aortic sections from WT (n = 3) and eLrrc8a KO (n = 3) mice immunostained with p-eNOS (H, green), andimmunofluorescence quantification of regions of WT (n = 5) and eLrrc8a KO (n = 5) endothelium (I). Scale bar in (H) is 50 mm. (J–L) Tail-cuff systolicblood pressures of male (J) and female (K) WT (n = 5 males and 7 females) and eLrrc8a KO (n = 5 males and 12 females) mice, and systolic bloodpressures of male WT (n = 4) and eLrrc8a KO (n = 5) mice under basal conditions and after 4 weeks of chronic angiotensin-II infusion (L). Statisticalsignificance between the indicated values is calculated using a two-tailed unpaired Student’s t-test. Error bars represent mean ± s.e.m. *p<0.05;**p<0.01; ***p<0.001.Alghanem et al. eLife 2021;10:e61313. DOI: https://doi.org/10.7554/eLife.61313 17 of 23Research article Cell BiologyFigure 8. Endothelium-specific Lrrc8a KO mice exhibit exacerbated impairments retinal microvascular disease in the setting of type 2 diabetes. (A)Representative fluorescein retinal angiograms of WT (top) and eLrrc8a KO (bottom) male (left) and female (right) mice raised on a high-fat high-sucroseFigure 8 continued on next pageAlghanem et al. eLife 2021;10:e61313. DOI: https://doi.org/10.7554/eLife.61313 18 of 23Research article Cell BiologyFigure 8 continued(HFHS) diet. Inset shows magnified view of retinal vessels. Quantification of major vessel fluorescence intensity over time after intraperitoneal (i.p.)fluorescein injection in (B) male (n = 3) and (C) female (n = 3) WT and eLrrc8a KO mice. (D–K) Quantification of total retinal vessel intensity (D), totalvessel number (E), vessel diameter (F), minimum vessel diameter (G), vessel area (H), total vessel length (I), lacunarity (J), number of end points (K), andbranching index (L) of retinal vessels in WT and eLrrc8a KO mice. Statistical significance between the indicated values for B and C was calculated usingtwo-way analysis of variance (ANOVA) and (D–L) using a two-tailed unpaired Student’s t-test. Error bars represent mean ± s.e.m. *p<0.05; **p<0.01;***p<0.001.Alghanem et al. eLife 2021;10:e61313. DOI: https://doi.org/10.7554/eLife.61313 19 of 23Research article Cell BiologyFigure 8—figure supplement 1. Endothelium-specific Lrrc8a KO mice exhibit mild retinal microvascular disease at baseline. Representative fluoresceinretinal angiograms of 13 week old WT (A) and eLrrc8a KO (B) mice raised on a regular diet. Inset shows magnified view of retinal vessels. (C–E)Quantification of major vessel fluorescence intensity over time after intraperitoenal (i.p.) fluorescein injection (C), maximum vessel diameter (D), andminimum vessel diameter (E) in WT (n = 11 mice) and eLrrc8a KO (n = 11 mice). (F–K) Quantification of explant area (F), lacunarity (G), vessel area (H),branching index (I), number of end points (J), and vessel length (K) in WT and eLrrc8a KO mice. Significance between the indicated groupswas calculated using a two-way analysis of variance (ANOVA) in (C) and a two-tailed Student’s t-test in (D–K). Error bars represent mean ± s.e.m.***p<0.001. Scale bar is 500 mm.Alghanem et al. eLife 2021;10:e61313. DOI: https://doi.org/10.7554/eLife.61313 20 of 23Research article Cell BiologyFigure 8—figure supplement 2. Endothelium-specific Lrrc8a KO mice exhibit exacerbated impairments retinalmicrovascular disease in the setting of type 2 diabetes. Three representative fluorescein retinal angiograms of WTand eLrrc8a KO from male (A) and female (B) mice raised on a high-fat high-sucrose (HFHS) diet for 10 months.Scale bar is 500 mm.Alghanem et al. eLife 2021;10:e61313. DOI: https://doi.org/10.7554/eLife.61313 21 of 23Research article Cell BiologyFigure 8—figure supplement 3. Glucose tolerance (GTT) and insulin tolerance (ITT) are not altered in endothelium-specific Lrrc8a KO mice (n = 13)compared to WT mice (n = 8) raised on a high-fat high-sucrose diet for 10 months. Significance between the indicated groups was calculated using atwo-way analysis of variance (ANOVA).Alghanem et al. eLife 2021;10:e61313. DOI: https://doi.org/10.7554/eLife.61313 22 of 23Research article Cell BiologyFigure 8—figure supplement 4. Body weight and body composition of WT and endothelium-specific Lrrc8a KO mice raised on a high-fat high-sucrosediet for 10 months. (A–E) Male WT (n = 6) and eLrrc8a KO (n = 7) mice body weight (A), %Lean mass (B), total lean mass (C), %Fat mass (D), total fatmass (E). (F–J) Female WT (n = 7) and eLRRC8A KO (n = 13) mice body weight (F), %Lean mass (G), total lean mass (H), %Fat mass (I), total fat mass (J).Significance between the indicated groups was calculated using a two-tailed Student’s t-test. Error bars represent mean ± s.e.m. *p<0.05; **p<0.01.Alghanem et al. eLife 2021;10:e61313. DOI: https://doi.org/10.7554/eLife.61313 23 of 23Research article Cell Biology

The SWELL1-LRRC8 complex regulates endothelial AKT-eNOS signaling and vascular function

https://digitalcommons.wustl.edu/cgi/viewcontent.cgi?filename=0&article=11184&context=open_access_pubs&type=additional

The SWELL1-LRRC8 complex regulates endothelial AKT-eNOS signaling and vascular function

Abstract

Similar works

Full text

Available Versions

Digital Commons@Becker